The outlook revision is based on a number of factors, including Moody’s Investors Service’s expectation that Vidant Health will maintain its current cash flow levels.
Moody’s also affirmed the “A1” rating assigned to Vidant Health’s $440 million of rated debt. The affirmation is based on Vidant’s strong market position in its service area.
More articles on healthcare finance:
Trump pledges to combat rising drug prices, ending pharma’s election ‘honeymoon’
Mutual of America Capital Management reduces stake in LifePoint
6 hospital CFOs in the headlines
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
